Additional researches focused on understanding the precise mechanism of action of KLHL14/TGF-β axis are still needed, including in vivo experiments and future clinical trials, to potentially develop KLHL14-based drugs that can be later be applied in MM and other deadly cancers with low therapeutic options. The gene discussed is TGFB1; the disease is cancer.